Skip to main content

Xromi

Pronunciation: ex-ro-mee
Generic name: hydroxyurea oral solution
Dosage form: oral solution
Drug class: Antimetabolites

Medically reviewed by Carmen Pope, BPharm. Last updated on Apr 23, 2024.

What is Xromi?

Xromi (hydroxyurea) is an oral solution that may be used to reduce the frequency of painful crises and reduce the need for blood transfusions in children aged 6 months to less than 2 years old, with sickle cell anemia who have recurrent moderate to severe painful crises.

How Xromi produces its beneficial effects in children with sickle cell anemia is not well understood although research has shown it increases HbF (fetal hemoglobin) levels, decreases neutrophils, increases the water content of red blood cells, increases the deformity of sickled cells, and changes how RBCs adhere to endothelium.

Xromi is not for use in adults. It is not known if Xromi is safe and effective in children less than 6 months old.

Xromi was FDA-approved on 4 April 2024. Hydroxyurea, the ingredient in Xromi, was first approved on December 7, 1967.

Xromi side effects

Xromi can cause serious side effects, such as low blood cell counts, and hemolytic anemia, and increase the risk of cancer. See warnings below.

Other serious side effects may include:

The most common side effects of Xromi affecting more than 33% of people include:

These are not all the possible side effects of Xromi. Call your child’s doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Warnings

Your child should not take Xromi if they are allergic to hydroxyurea, Xromi, or any of the inactive ingredients in the solution.

Xromi can cause severe bone marrow suppression and should not be given to children whose bone marrow function is markedly depressed.

Xromi can cause serious side effects including:

Research has shown the active ingredient in Xromi, hydroxyurea, may cause fertility problems in males and harm to an unborn baby.  Xromi is not approved in adults but you should talk to your child’s healthcare provider if this is a concern.

Before taking

Before your child takes Xromi, tell your child’s healthcare provider about all of their medical conditions, including if your child:

How is Xromi administered?

Parents and caregivers should read the Instructions for Use that come with Xromi for information about the right way to measure and give a dose. If you have any questions, talk to your child’s healthcare provider or pharmacist.

Xromi dosage

Administer Xromi exactly as your child’s healthcare provider tells you to administer it.

Oral dosing syringes should be rinsed washed with cold or warm water and dried completely before the next use. Store oral dosing syringes in a clean place in the refrigerator with the medicine.

During treatment with Xromi, your child’s healthcare provider will do blood tests regularly to check your child’s blood cell counts and liver function. Your healthcare provider may change your child’s dose if you have side effects.

What happens if I give my child too much Xromi?

If you give your child too much Xromi, call your child’s healthcare provider or go to the nearest hospital emergency room right away.

What other drugs will affect Xromi?

Tell your doctor about all the medicines that your child takes, including prescription and nonprescription medicines, vitamins, and herbal supplements. Xromi and some medicines may interact with each other and may not work as well, or cause possible serious side effects. Especially tell your doctor if your child takes:

Xromi may interfere with laboratory tests that measure uric acid, urea, or lactic acid, rendering falsely elevated results.

Xromi may also falsely elevate sensor glucose results from certain continuous glucose monitoring (CGM) systems and may lead to low blood glucose levels if sensor glucose results are relied upon to dose insulin.

This is not a complete list of interactions. Talk to your healthcare provider or pharmacist for a full list of interactions.

Storage

Refrigerate Xromi in a clean part of the refrigerator between 35°F to 46°F (2°C to 8°C). Do not freeze. It comes in a bottle with a child-resistant cap. Keep the bottle tightly closed.

Use Xromi oral solution within 12 weeks of opening the bottle. Dispose of (throw away) any unused medicine and the dosing syringes after 12 weeks.

Xromi is a hazardous drug. Place the finished Xromi bottle and syringes in a plastic bag and ask your pharmacist for instructions on how to throw away (dispose of) Xromi that is expired or no longer needed.

Do not use after the expiration date on the carton and bottle.

Keep out of the reach of children. Accidental ingestion can be lethal for children.

Ingredients

Active ingredient: hydroxyurea

Inactive ingredients: methyl parahydroxybenzoate, purified water, sodium hydroxide, strawberry flavor, sucralose, and xanthan gum.

Manufacturer

Nova Laboratories Ltd. for Rare Disease Therapeutics, Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.